These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8607724)

  • 1. Cost-effectiveness of HIV screening in acute care settings.
    Owens DK; Nease RF; Harris RA
    Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
    Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
    N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who should be screened for HIV infection? A cost-effectiveness analysis.
    McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
    Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.
    Dowdy DW; Rodriguez RM; Hare CB; Kaplan B
    Acad Emerg Med; 2011 Jul; 18(7):745-53. PubMed ID: 21762236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of undiagnosed HIV infection in hospitalized patients: assessment by linkage of seroprevalence and surveillance methods.
    Trepka MJ; Davidson AJ; Douglas JM
    Am J Prev Med; 1996; 12(3):195-202. PubMed ID: 8743875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
    J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of screening health care workers for HIV.
    Chavey WE; Cantor SB; Clover RD; Reinarz JA; Spann SJ
    J Fam Pract; 1994 Mar; 38(3):249-57. PubMed ID: 8126405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
    Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening women of childbearing age for human immunodeficiency virus. A cost-benefit analysis.
    Brandeau ML; Owens DK; Sox CH; Wachter RM
    Arch Intern Med; 1992 Nov; 152(11):2229-37. PubMed ID: 1444682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs.
    Li J; Gilmour S; Zhang H; Koyanagi A; Shibuya K
    AIDS; 2012 Oct; 26(16):2069-78. PubMed ID: 22781221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing an HIV and sexually transmitted disease screening program in an emergency department.
    Silva A; Glick NR; Lyss SB; Hutchinson AB; Gift TL; Pealer LN; Broussard D; Whitman S
    Ann Emerg Med; 2007 May; 49(5):564-72. PubMed ID: 17113684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high-risk population.
    Desormeaux J; Johnson MP; Coberly JS; Losikoff P; Johnson E; Huebner R; Geiter L; Davis H; Atkinson J; Chaisson RE; Boulos R; Halsey NA
    Bull Pan Am Health Organ; 1996 Mar; 30(1):1-8. PubMed ID: 8919719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient acceptance of rapid HIV testing practices in an urban emergency department: assessment of the 2006 CDC recommendations for HIV screening in health care settings.
    Haukoos JS; Hopkins E; Byyny RL;
    Ann Emerg Med; 2008 Mar; 51(3):303-9, 309.e1. PubMed ID: 18191295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of HIV screening in pregnant women in hospitals in the Paris region].
    Le Galès C; Moatti JP
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(1):36-42. PubMed ID: 2107247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.